Anti-Mullerian Hormone (AMH)
This a hormone level which will be measured early in a donor’s cycle to determine her ovarian reserve. This will be one of the first tests done to determine eligibility to donate once selected.
This is a program of events which patients/donors will follow while they are undergoing ovarian stimulation protocols. It is computer generated, so that as adjustments are made while the patient is in cycle, the calendar can be continuously updated in terms of dosages and duration of medication administration. The calendar allows all parties to easily plan around the treatment. It allows the patient to know exactly what she is expected to do on each day and project the anticipated dates of egg retrieval and/or embryo transfer. It also helps the medical team prepare for patients in cycle.
The term given to a pregnancy which is evident based on a positive blood or urine pregnancy test. Pregnancy is not confirmed or considered a clinical pregnancyuntil visualized by ultrasound.
A pregnancy that has been confirmed by ultrasound examination. At this point the doctor can visualize fetal heartbeat.
A cycle is a generic term which usually includes everything a patient undergoes for her treatment through 1 full attempt. A cycle either begins with the onset of menstruation in ‘un-programmed’ treatments, or at the commencement of medication in ‘programmed cycles’. Most busy centers batch cases and are able to do so using a combination of birth control pills and/or Lupron and/or GnRH antagonists (a class of drugs to rapidly prevent the release of GnRH from the hypothalamus). The cycle usually ends roughly 14 days after an embryo transfer or with the onset of the next menstrual flow.
Cycle day three blood tests
These tests are usually performed to indicate ovarian reserve. Cycle day 3 is the third day of a full menstrual flow. Tests usually include any or all of serum FSH levels, Serum Estradiol levels, and Serum Inhibin B levels. Studies have been done which allow doctors to interpret the results of such tests (along with other tests such as antral follicle counts which is the number of small follicles as seen on ultrasound at the beginning of a cycle), to anticipate that the patient will be a poor responder or not, while undergoing stimulation with gonadotropins.
A pregnancy that occurs when the embryo implants in a location other than the uterus. Often the embryo implants in the fallopian tube. In almost all instances, these cases require surgical intervention.